Silicon Labs Reports Third Quarter 2026 Results
Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for the third quarter, which ended October 3, 2026.
“We delivered strong third-quarter results, with revenue up 10% sequentially, underpinned by broad-based growth across many end applications and another record quarter for medical revenue as known customer ramps continued,” said Matt Johnson, President and Chief Executive Officer. “Earnings significantly outpaced revenue growth, a result of strong operational execution by the team. Looking ahead, our current backlog and design-win ramps position us for continued revenue growth and meaningful earnings expansion.”
• Bookings imply a healthy demand environment, while distributor inventory declined further to a multi-year low and end customer inventory was near record lows during the quarter
• Medical revenue reached a new quarterly record, increasing 48% sequentially and more than 300% year-over-year
• GAAP diluted earnings per share was $0.26, compared with a loss of $0.30 in the year-ago quarter
• Non-GAAP diluted earnings per share was $1.05, up 228% over the comparable period last year
Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, merger-related costs, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:
Due to the announced pending acquisition of Silicon Labs by Texas Instruments, Silicon Labs has suspended providing forward-looking guidance.
Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the
trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.
This press release contains forward-looking statements regarding Silicon Labs’ current expectations, which are based on its current views and assumptions. The words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”, “project”, “will”, and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements, although the absence of such words does not necessarily mean a statement is not forward looking. These forward-looking statements include, but are not necessarily limited to, Silicon Labs’ expectations regarding its near- and long-term strength and continued revenue growth and earnings expansion and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations that are expressed or implied herein. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: our ability to complete the merger with Texas Instruments within the time frame expected, or at all, as well as potential disruptions in our business and restrictions on our activities during the pendency of the merger; fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the impact of the current global memory chip shortage; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
For more information: Silicon Labs Investor Relations, [email protected]
In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations. Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
October 3, January 3, 2026 2026 ─────────────────────────────────────────────────────────────────────────── Assets Current assets: Cash and cash equivalents $ 423,013 $ 364,222 Short-term investments 16,828 79,400 Accounts receivable, net 79,966 64,513 Inventories 133,391 95,566 Prepaid expenses and other current 71,421 70,316 assets Total current assets 724,619 674,017 Property and equipment, net 131,687 128,643 Goodwill 376,389 376,389 Other intangible assets, net 16,246 23,130 Other assets, net 87,213 67,138 Total assets $ 1,336,154 $ 1,269,317 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 68,860 $ 50,717 Deferred revenue and returns liability 9,804 5,359 Other current liabilities 78,841 87,711 Total current liabilities 157,505 143,787 Other non-current liabilities 53,267 31,112 Total liabilities 210,772 174,899 Commitments and contingencies Stockholders’ equity: Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares — — issued Common stock – $0.0001 par value; 250,000 shares authorized; 33,384 and 32,955 shares issued and outstanding at 3 3 October 3, 2026 and January 3, 2026, respectively Additional paid-in capital 206,203 157,402 Retained earnings 919,176 936,814 Accumulated other comprehensive income — 199 Total stockholders’ equity 1,125,382 1,094,418 Total liabilities and stockholders’ $ 1,336,154 $ 1,269,317 equity
October 3, October 4, Nine Months Ended 2026 2025 ────────────────────────────────────────────────────────────────────────────── Operating Activities Net loss $ -17,638 $ -62,223 Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation of property 18,154 18,769 and equipment Amortization of other 6,884 11,074 intangible assets Stock-based compensation 69,754 59,645 expense Deferred income taxes 2,164 2,026 Changes in operating assets and liabilities: Accounts receivable -15,453 -12,829 Inventories -37,828 23,316 Prepaid expenses and other -35,213 9,080 assets Accounts payable 18,373 11,141 Other current liabilities and income 3,271 29,901 taxes Deferred revenue and 4,445 5,374 returns liability Other non-current 20,285 -7,916 liabilities Net cash provided by operating 37,198 87,358 activities Investing Activities Purchases of marketable — -34,790 securities Sales of marketable — 15,332 securities Maturities of marketable 62,309 22,598 securities Purchases of property and -28,472 -19,942 equipment Proceeds from capital-related government 8,705 — incentives Purchase of other — -4,000 investment Net cash provided by (used in) investing 42,542 -20,802 activities Financing Activities Payment of taxes withheld for vested -28,710 -14,907 stock awards Proceeds from the issuance of common 7,761 8,147 stock Net cash used in financing -20,949 -6,760 activities Increase in cash and cash 58,791 59,796 equivalents Cash and cash equivalents at beginning 364,222 281,607 of period Cash and cash equivalents at end of $ 423,013 $ 341,403 period
Full text with the tables
Exhibit 99
Silicon Labs Reports Third Quarter 2026 Results
Wireless IoT leader delivers $251 million in revenue and strong earnings growth
AUSTIN, Texas – November 10, 2026 –
Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless,
reported financial results for the third quarter, which ended October 3, 2026.
“We delivered strong third-quarter results, with revenue up 10% sequentially,
underpinned by broad-based growth across many end applications and another
record quarter for medical revenue as known customer ramps continued,” said Matt
Johnson, President and Chief Executive Officer. “Earnings significantly outpaced
revenue growth, a result of strong operational execution by the team. Looking
ahead, our current backlog and design-win ramps position us for continued
revenue growth and meaningful earnings expansion.”
Third Quarter Financial Highlights
• Revenue was $251 million, up 22% year-over-year
• Industrial & Commercial revenue was $141 million, up 20% year-over-year
• Home & Life revenue was $110 million, up 24% year-over-year
• Bookings imply a healthy demand environment, while distributor inventory
declined further to a multi-year low and end customer inventory was near record
lows during the quarter
• Medical revenue reached a new quarterly record, increasing 48% sequentially
and more than 300% year-over-year
• GAAP diluted earnings per share was $0.26, compared with a loss of $0.30 in
the year-ago quarter
• Non-GAAP diluted earnings per share was $1.05, up 228% over the comparable
period last year
Results on a GAAP basis:
• GAAP gross margin was 60.8%
• GAAP operating expenses were $145 million
• GAAP operating income was $8 million
• GAAP diluted earnings per share was $0.26
Results on a non-GAAP basis, excluding the impact of stock compensation,
amortization of acquired intangible assets, merger-related costs, and certain
other items as set forth in the below GAAP to Non-GAAP reconciliation tables
were as follows:
• Non-GAAP gross margin was 61.0%
• Non-GAAP operating expenses were $113 million
• Non-GAAP operating income was $40 million
• Non-GAAP diluted earnings per share was $1.05
Due to the announced pending acquisition of Silicon Labs by Texas Instruments,
Silicon Labs has suspended providing forward-looking guidance.
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless
connectivity, building embedded technology that connects devices and improves
lives. Merging cutting-edge technology into the world's most highly integrated
SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems
needed to create advanced edge connectivity applications. Headquartered in
Austin, Texas, Silicon Labs has operations in over 16 countries and is the
trusted partner for innovative solutions in the smart home, industrial IoT, and
smart cities markets. Learn more at silabs.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding Silicon Labs’
current expectations, which are based on its current views and assumptions. The
words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”,
“project”, “will”, and similar phrases as they relate to Silicon Labs are
intended to identify such forward-looking statements, although the absence of
such words does not necessarily mean a statement is not forward looking. These
forward-looking statements include, but are not necessarily limited to, Silicon
Labs’ expectations regarding its near- and long-term strength and continued
revenue growth and earnings expansion and are subject to various risks and
uncertainties that could cause actual results to differ materially from
expectations that are expressed or implied herein. Among the factors that could
cause actual results to differ materially from those in the forward-looking
statements are the following: our ability to complete the merger with Texas
Instruments within the time frame expected, or at all, as well as potential
disruptions in our business and restrictions on our activities during the
pendency of the merger; fluctuating changes in global trade policies, including
the imposition of tariffs, duties, trade sanctions, or other barriers to
international commerce; the impact of the current global memory chip shortage;
the competitive and cyclical nature of the semiconductor industry; the
challenging macroeconomic environment, including disruptions in the financial
services industry; geographic concentration of manufacturers, assemblers, test
service providers and customers in Asia that subjects Silicon Labs’ business and
results of operations to risks of natural disasters, epidemics or pandemics, war
and political unrest; risks that demand and the supply chain may be adversely
affected by military conflict (including in the Middle East, and between Russia
and Ukraine), terrorism, sanctions or other geopolitical events globally
(including in the Middle East, and conflict between Taiwan and China); risks
that Silicon Labs may not be able to maintain its historical growth; quarterly
fluctuations in revenues and operating results; difficulties developing new
products that achieve market acceptance; risks associated with international
activities (including trade barriers, particularly with respect to China);
intellectual property litigation risks; risks associated with acquisitions and
divestitures; product liability risks; difficulties managing and/or obtaining
sufficient supply from Silicon Labs’ distributors, manufacturers and
subcontractors; dependence on a limited number of products; absence of long-term
commitments from customers; inventory-related risks; difficulties managing
international activities; risks that Silicon Labs may not be able to manage
strains associated with its growth; credit risks associated with its accounts
receivable; dependence on key personnel; stock price volatility; the impact of
public health crises on the U.S. and global economy; debt-related risks;
capital-raising risks; the timing and scope of share repurchases and/or
dividends; average selling prices of products may decrease significantly and
rapidly; information technology risks; cyber-attacks against Silicon Labs’
products and its networks; risks associated with any material weakness in our
internal controls over financial reporting; risks relating to compliance with
laws and regulations; and other factors that are detailed in the SEC filings of
Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by law. References
in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the
Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product
names noted herein may be trademarks of their respective holders.
For more information: Silicon Labs Investor Relations,
[email protected]
Silicon Laboratories Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
Thr… Oct… Oct… Nine Oct… Oct…
Mon… 3, 4, Mon… 3, 4,
End… 2026 2025 End… 2026 2025
──────────────────────────────────────────────────────────────────────────────
Re… $ 250… $ 205… $ 692… $ 576…
Co…
of 98,… 86,… 272… 251…
re…
Gr… 152… 119… 420… 324…
pr…
Op…
ex…
Re…
and 93,… 87,… 276… 263…
de…
Se…
ge… 51,… 43,… 163… 128…
and
ad…
Op… 144… 131… 440… 392…
ex…
Op…
in… 7,9… -12… -19… -67…
(l…
Ot…
in…
(e…
In…
in…
and 3,1… 3,0… 9,3… 10,…
ot…
net
In… -226 -226 -709 -761
ex…
In…
(l…
be… 10,… -9,… -11… -57…
in…
ta…
Pr…
for 2,0… 414 6,4… 4,8…
in…
ta…
Net
in… $ 8,8… $ -9,… $ -17… $ -62…
(l…
Ea…
(l…
per
sh…
Ba… $ 0.27 $ -0.… $ -0.… $ -1.…
Di… $ 0.26 $ -0.… $ -0.… $ -1.…
We…
co…
sh…
ou…
Ba… 33,… 32,… 33,… 32…
Di… 33,… 32,… 33,… 32…
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this document, Silicon Labs
has provided non-GAAP financial measurements on a basis excluding non-cash and
other charges and benefits. Details of these excluded items are presented in the
tables below, which reconcile the GAAP results to non-GAAP financial
measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon
Labs’ GAAP financial results. These measurements provide supplemental
information to assist management and investors in analyzing Silicon Labs’
financial position and results of operations. Silicon Labs has chosen to provide
this information to investors to enable them to perform meaningful comparisons
of past, present and future operating results and as a means to emphasize the
results of core on-going operations.
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
T…
M…
E…
O…
3,
2…
──────────────────────────────────────────────────────────────────────────────
… G… S… I… N…
… G… P… C… A… M… N… P…
… M… of E… A… C… M… of
… R… R…
… $ 2…
… 1… 6… % $ 4… $ — $ — $ 1… … %
…
…
… 9… 3… % 1… 2… 3… 7… … %
…
…
… 5… 2… % 1… — 3… 3… … %
…
…
… 1… 5… % 2… 2… 6… 1… … %
…
… 7… 3… % 2… 2… 6… 4… … %
…
Th…
Mo…
En…
Oc…
3,
20…
──────────────────────────────────────────────────────────────────────────────
… S… I… I… No…
… GA… C… A… M… T… GA…
… Me… E… A… C… A… Me…
…
…
… $ 8… $ 23… $ 2,… $ 6,… $ -5… $ 3…
…
…
… 33… 3…
…
…
… $ 0… $ 1…
…
…
* Represents pre-tax amounts
** Represents the application of an 18% non-GAAP tax rate
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
October 3, January 3,
2026 2026
───────────────────────────────────────────────────────────────────────────
Assets
Current assets:
Cash and cash equivalents $ 423,013 $ 364,222
Short-term investments 16,828 79,400
Accounts receivable, net 79,966 64,513
Inventories 133,391 95,566
Prepaid expenses and other current 71,421 70,316
assets
Total current assets 724,619 674,017
Property and equipment, net 131,687 128,643
Goodwill 376,389 376,389
Other intangible assets, net 16,246 23,130
Other assets, net 87,213 67,138
Total assets $ 1,336,154 $ 1,269,317
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable $ 68,860 $ 50,717
Deferred revenue and returns liability 9,804 5,359
Other current liabilities 78,841 87,711
Total current liabilities 157,505 143,787
Other non-current liabilities 53,267 31,112
Total liabilities 210,772 174,899
Commitments and contingencies
Stockholders’ equity:
Preferred stock – $0.0001 par value;
10,000 shares authorized; no shares — —
issued
Common stock – $0.0001 par value;
250,000 shares authorized; 33,384 and
32,955 shares issued and outstanding at 3 3
October 3, 2026 and January 3, 2026,
respectively
Additional paid-in capital 206,203 157,402
Retained earnings 919,176 936,814
Accumulated other comprehensive income — 199
Total stockholders’ equity 1,125,382 1,094,418
Total liabilities and stockholders’ $ 1,336,154 $ 1,269,317
equity
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
October 3, October 4,
Nine Months Ended 2026 2025
──────────────────────────────────────────────────────────────────────────────
Operating Activities
Net loss $ -17,638 $ -62,223
Adjustments to reconcile
net loss to net
cash provided by operating
activities:
Depreciation of property 18,154 18,769
and equipment
Amortization of other 6,884 11,074
intangible assets
Stock-based compensation 69,754 59,645
expense
Deferred income taxes 2,164 2,026
Changes in operating
assets and
liabilities:
Accounts receivable -15,453 -12,829
Inventories -37,828 23,316
Prepaid expenses and other -35,213 9,080
assets
Accounts payable 18,373 11,141
Other current liabilities
and income 3,271 29,901
taxes
Deferred revenue and 4,445 5,374
returns liability
Other non-current 20,285 -7,916
liabilities
Net cash provided by
operating 37,198 87,358
activities
Investing Activities
Purchases of marketable — -34,790
securities
Sales of marketable — 15,332
securities
Maturities of marketable 62,309 22,598
securities
Purchases of property and -28,472 -19,942
equipment
Proceeds from
capital-related government 8,705 —
incentives
Purchase of other — -4,000
investment
Net cash provided by (used
in) investing 42,542 -20,802
activities
Financing Activities
Payment of taxes withheld
for vested -28,710 -14,907
stock awards
Proceeds from the issuance
of common 7,761 8,147
stock
Net cash used in financing -20,949 -6,760
activities
Increase in cash and cash 58,791 59,796
equivalents
Cash and cash equivalents
at beginning 364,222 281,607
of period
Cash and cash equivalents
at end of $ 423,013 $ 341,403
period